Who is sponsoring NCT02625675?

NCT02625675 is sponsored by University of Oxford.

What drugs are being tested in NCT02625675?

Interventions in NCT02625675: Ultrasound scan.

What condition does NCT02625675 study?

NCT02625675 studies Malignant Pleural Effusion.

Is NCT02625675 still recruiting?

NCT02625675 is currently completed. Last updated 9 January 2018.

Last reviewed 2018-01-09 · How we verify

NCT02625675

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study

Completed Last updated 9 January 2018

What this trial tests

trial testing Ultrasound scan in Malignant Pleural Effusion in 18 participants. Completed in 6 July 2017.

Timeline

19 March 2015

Primary endpoint
6 July 2017

6 July 2017

Quick facts

Lead sponsor	University of Oxford
Status	Completed
Study type	OBSERVATIONAL
Enrollment	18
Start date	19 March 2015
Primary completion	6 July 2017
Estimated completion	6 July 2017
Sites	1 location across United Kingdom

Drugs / interventions tested

Ultrasound scan

Conditions studied

Malignant Pleural Effusion — all drugs for Malignant Pleural Effusion →

Sponsor

University of Oxford

Who can join

18 and older, any sex, with Malignant Pleural Effusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The observational pilot study at the Churchill Hospital, funded by Oxford Respiratory Trials Unit, will assess the feasibility and efficacy of thoracic ultrasound (TUS) assessment in patients undergoing talc pleurodesis via intercostal chest drain (ICD) for recurrent symptomatic malignant pleural effusions (MPE). Participants will undergo TUS pre and post pleurodesis on up to four occasions. We hypothesise that a TUS scoring system will be able to predict short and long-term pleurodesis success earlier than current conventional medical practice allows. This study may ultimately allow the proposal of a treatment algorithm to manage patients with MPE in a more efficient manner.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
Corcoran JP, Hallifax RJ, Mercer RM, Yousuf A, et al · · 2018 · cited 16× · PMID 30243566 · DOI 10.1016/j.chest.2018.08.1031

Verify or expand the search:

Other trials of Ultrasound scan

Trials testing the same drug.

NCT04857476 — Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound? · NA · terminated
NCT04194736 — Evaluation of the Occurrence of Early Thrombosis on Central Venous Catheter by Ultrasound in Pediatric Intensive Care Un · NA · completed
NCT04547270 — High Definition Ultrasound Imaging of the Intermuscular Bridges at the Interscalene Groove · completed
NCT04127149 — Evaluation of Ultra-portable Ultrasound in General Practice · NA · completed
NCT02946229 — Data Collection for Next Generation Ultrasound Technology Development · NA · completed

Other recruiting trials for Malignant Pleural Effusion

Currently open trials in the same condition.

NCT06421610 — OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. · Phase 1 · recruiting
NCT05620329 — UNC Pleural Fluid Registry · recruiting

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02625675 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 9 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02625675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing